M&A Deal Summary

Clariant AG Acquires Sud-Chemie AG

On February 17, 2011, Clariant AG acquired chemicals company Sud-Chemie AG from One Equity Partners for 1.4B EUR

Acquisition Highlights
  • This is Clariant AG’s 1st transaction in the Chemicals sector.
  • This is Clariant AG’s 0th largest (disclosed) transaction.
  • This is Clariant AG’s 1st transaction in Germany.

M&A Deal Summary
Date 2011-02-17
Target Sud-Chemie AG
Sector Chemicals
Buyer(s) Clariant AG
Sellers(s) One Equity Partners
Deal Type Add-on Acquisition
Deal Value 1.4B EUR

Target

Sud-Chemie AG

Munich, Germany
Süd-Chemie is a specialty chemicals company headquartered in Munich, Germany and operating on a worldwide scale. Products manufactured by the Catalysts Division offer solutions for the chemical, petrochemical and refinery industries, for energy storage and hydrogen production, as well as off-gas purification. Key markets served by its Adsorbents Division include the consumer goods, packaging and foundry industries, as well water treatment.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Clariant AG

Muttenz, Switzerland
Category Company
Founded 1995
Sector Chemicals
DESCRIPTION

Clariant AG is a specialty chemicals company. Clariant offers chemicals such as adsorbents, biocides, industrial ingredients, and detergents, as well as chemicals and dyes for textiles, leather, and paper. Clariant also manufacturers de-icing agents and fire retardants.

DEAL STATS #
Overall 1 of 11
Sector (Chemicals) 1 of 8
Type (Add-on Acquisition) 1 of 8
Country (Germany) 1 of 2
Year (2011) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-08-31 SiVance

Gainesville, North Carolina, United States

SiVance, LLC is a producer of silicone-based products for the personal care, pharmaceutical, construction and electronics markets.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-10-26 OTC

Oberhausen, Germany

OTC provides formulation expertise to transform new sustainable and innovative technologies into cost efficient consumer products. OTC has a leading position in development of delivery technologies for micronized active ingredients, which offer customers in consumer care markets innovative solutions in cosmetic, food or other application areas.

Buy -

Seller(S) 1

SELLER

One Equity Partners

New York, New York, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2001
PE ASSETS 10.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

One Equity Partners (OEP) is a private equity firm that targets buyout and growth capital investments in North America, Europe, and Asia. OEP prefers to be the lead investor and typically commits $30 to $300 million per transaction. Sectors of interest include industrial products/services, consumer, retail, chemicals, media, communications, and healthcare. One Equity Partners was formed in 2001 and spun out of JP Morgan Chase in 2015. One Equity Partners is based in New York City.

DEAL STATS #
Overall 7 of 63
Sector (Chemicals) 1 of 5
Type (Add-on Acquisition) 6 of 36
Country (Germany) 1 of 3
Year (2011) 1 of 5
Size (of disclosed) 1 of 20
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-02-04 Chemlogics Group

Paso Roble, California, United States

Chemlogics provides the energy sector with specialty chemicals used in the extraction and production of oil and gas.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-04-28 Prodigy Health Group

New York, New York, United States

Prodigy Health Group provides benefits management, integrated health management, provider network services and insurance services to self-funded employers, managed care companies and insurers. Prodigy Health companies serve more than 4 million members across all industry sectors.

Sell $600M
Mergr

Product

Company

Legal